Cancer Therapy News and Research

RSS

Scientists bioengineer novel molecule to kill tumour cells

Scientists from Nanyang Technological University and Lund University, Sweden, have bioengineered a novel molecule which has been proven to successfully kill tumour cells.

21 May 2013

PGDx to identify novel kinase targets in collaboration with Blueprint Medicines

Personal Genome Diagnostics Inc., today announced that it will use its proprietary methodologies and expertise in genomic analysis of defined cancer subtypes to identify novel kinase targets in collaboration with Blueprint Medicines.

21 May 2013

Researchers say that receiving cancer radiation therapy late in the day may minimize hair loss

Discovering that mouse hair has a circadian clock - a 24-hour cycle of growth followed by restorative repair - researchers suspect that hair loss in humans from toxic cancer radiotherapy and chemotherapy might be minimized if these treatments are given late in the day.

21 May 2013

UCLA study: Older men with multiple underlying health problems should avoid prostate cancer treatment

Older prostate cancer patients with other underlying health conditions should think twice before committing to surgery or radiation therapy for their cancer, according to a multicenter study led by researchers in the UCLA Department of Urology.

21 May 2013

Cancer survivors suffer diverse, complex set of impairments, new review finds

A new review finds cancer survivors suffer a diverse and complex set of impairments, affecting virtually every organ system.

17 May 2013

Columbia University signs licensing agreement with Varian Medical Systems for novel imaging software

Columbia University has signed a licensing agreement with Varian Medical Systems for novel imaging software that facilitates 3-D segmentation, the process by which anatomical structures in medical images are distinguished from one another-an important step in the precise planning of cancer surgery and radiation treatments.

17 May 2013

Doctors can play role in easing financial worries of cancer patients

Most cancer patients would like to talk about the cost of their care with their doctors, but often don't because they fear the discussion could compromise the quality of their treatment, researchers at Duke Cancer Institute report.

17 May 2013

Symposium examines racial and ethnic health disparities on cancer care

Third-year residents in the Department of Family and Community Medicine at Thomas Jefferson University Hospital have organized a symposium examining racial and ethnic health disparities, with a focus on cancer care. The program will feature a keynote speech from Otis Brawley, MD, Chief Medical Officer of the American Cancer Society.

16 May 2013

Study finds broader set of concerns for improving quality of life

The majority of cancer doctors, patients, and members of the general public support cutting health care costs by refusing to pay for drugs that don't improve survival or quality of life, according to results of a new study that will be presented by researchers from the Perelman School of Medicine at the University of Pennsylvania during the annual meeting of the American Society of Clinical Oncology in Chicago in early June (Abstract #6518).

16 May 2013

Study underscores new paradigm in cancer therapy

In the largest clinical trial to date to examine the efficacy of PARP inhibitor therapy in BRCA 1/2 carriers with diseases other than breast and ovarian cancer, the oral drug olaparib was found to be effective against advanced pancreatic and prostate cancers.

16 May 2013

Breast cancer patients treated with chemotherapy show improved executive function after cognitive training

Women whose breast cancer had been treated with chemotherapy demonstrated improved executive function, such as cognitive flexibility, verbal fluency and processing speed after using exercises developed by Lumosity, the leading online cognitive training program.

15 May 2013

Researchers demonstrate how EGF accelerates division of cell nucleus

Biologists at Heidelberg University have discovered new approaches for the treatment of cancer. They investigated how a special signalling molecule, the epidermal growth factor (EGF), stimulates the separation of chromosomes in the cell. The researchers were able to demonstrate that EGF accelerates the division of the cell nucleus, i.e. mitosis, as well as boosts precision in chromosome segregation.

15 May 2013

Tokai Pharmaceuticals raises $35.5M in Series E financing

Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that the company raised $35.5 million in a Series E financing based on encouraging clinical progress and investor support for galeterone (TOK-001), Tokai's lead prostate cancer drug candidate.

15 May 2013

ASPS strongly supports Breast Cancer Patient Education Act

The American Society of Plastic Surgeons today announced its strong support of the "Breast Cancer Patient Education Act" (S. 931). This bipartisan legislation is being introduced today, coinciding with National Women's Health Week, in the U.S. House of Representatives by Reps. Leonard Lance (R-NJ) and Donna Christensen, M.D. (D-VI) and in the United States Senate by Sens. Roy Blunt (R-MO), Sherrod Brown (D-OH) and David Vitter (R-LA).

15 May 2013

Researchers show how cells are driven mainly by water power

Water gives life. Researchers at Linköping University in Sweden now show how the cells in our bodies are driven mainly by water power - a discovery that in the long run opens the way for a new strategy in cancer therapy.

14 May 2013

ScinoPharm Taiwan, Coland Holdings partner to develop generic oncological drugs for China

ScinoPharm Taiwan Ltd. and Coland Holdings Ltd. announced today that they have formed a strategic alliance to develop a series of generic oncological drugs for Mainland China.

10 May 2013

New data help explain hospital pricing, but experts caution that Medicare and insurers get much lower rates

Although the government releases a list of what hospitals across the country charge for common procedures in an effort to make health costs more transparent, few patients or their insurers pay that.

10 May 2013

Researchers discover novel mechanism of tumor hypoxia

An article published recently in Tumor Microenvironment and Therapy - an open access journal by Versita, defines a novel mechanism of tumor hypoxia induced by the longitudinal gradient of residual oxygen along tumor vessels as they transverse the tumor.

10 May 2013

USF, Aetna to examine influence of genetic testing on breast cancer treatment

The University of South Florida and Aetna are launching a ground-breaking study that will examine the influence genetic testing may have on clinical treatment decisions among breast cancer patients and their doctors.

10 May 2013

Drug resistant brain tumors: an interview with Prof. Mischel, Ludwig Institute for Cancer Research and Prof. Bensinger, University of California

In cancer, mutations in proteins that control cell growth are common, leading to unrestrained cellular proliferation and tumor formation.

9 May 2013

Cancer Therapy News and Research

Scientists bioengineer novel molecule to kill tumour cells

PGDx to identify novel kinase targets in collaboration with Blueprint Medicines

Researchers say that receiving cancer radiation therapy late in the day may minimize hair loss

UCLA study: Older men with multiple underlying health problems should avoid prostate cancer treatment

Cancer survivors suffer diverse, complex set of impairments, new review finds

Columbia University signs licensing agreement with Varian Medical Systems for novel imaging software

Doctors can play role in easing financial worries of cancer patients

Symposium examines racial and ethnic health disparities on cancer care

Study finds broader set of concerns for improving quality of life

Study underscores new paradigm in cancer therapy

Breast cancer patients treated with chemotherapy show improved executive function after cognitive training

Researchers demonstrate how EGF accelerates division of cell nucleus

Tokai Pharmaceuticals raises $35.5M in Series E financing

ASPS strongly supports Breast Cancer Patient Education Act

Researchers show how cells are driven mainly by water power

ScinoPharm Taiwan, Coland Holdings partner to develop generic oncological drugs for China

New data help explain hospital pricing, but experts caution that Medicare and insurers get much lower rates

Researchers discover novel mechanism of tumor hypoxia

USF, Aetna to examine influence of genetic testing on breast cancer treatment

Drug resistant brain tumors: an interview with Prof. Mischel, Ludwig Institute for Cancer Research and Prof. Bensinger, University of California

Event guide: 7th Allogeneic Cell Therapies Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News